Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes.

Jiang, Hui-Zhong; Yang, Bing; Jiang, Ya-Li; Liu, Xun; Chen, Da-Lin; Long, Feng-Xi; Yang, Zhu; Tang, Dong-Xin

Jiang, Hui-Zhong; Yang, Bing; Jiang, Ya-Li; Liu, Xun; Chen, Da-Lin; Long, Feng-Xi; Yang, Zhu; Tang, Dong-Xin.

Afiliación

Jiang HZ; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Yang B; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Jiang YL; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Liu X; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Chen DL; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Long FX; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Yang Z; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Tang DX; College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China.

Front Oncol ; 12: 1025397, 2022.

Article en En | MEDLINE | ID: mdl-36387195

Palabras clave

colon adenocarcinoma; immune; metabolism; prognosis; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google